Neoantigens Market Growth Accelerating Toward US$ 5,607.32 Million by 2034
Neoantigens are mutation-driven epitopes that emerge from genetic instability within cancer cells, creating novel targets not found in normal human tissues. Because they are entirely tumor-specific, they bypass central immune tolerance and can provoke strong, selective immune responses. This distinct biological property positions neoantigens at the forefront of precision immuno-oncology and...
0 Reacties 0 aandelen 339 Views 0 voorbeeld